RNAGADE Trademark

Trademark Overview


On Wednesday, February 24, 2021, a trademark application was filed for RNAGADE with the United States Patent and Trademark Office. The USPTO has given the RNAGADE trademark a serial number of 90545048. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, October 15, 2025. This trademark is owned by Renagade Therapeutics LLC. The RNAGADE trademark is filed in the Chemical Products category with the following description:

Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, na...
rnagade

General Information


Serial Number90545048
Word MarkRNAGADE
Filing DateWednesday, February 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements


Pseudo MarkRENAGADE RENEGADE
Goods and ServicesBiochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for scientific or medical research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, May 26, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRenagade Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWatertown, MA 02472

Party NameRenagade Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, December 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 27, 2021NEW APPLICATION ENTERED
Wednesday, May 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 26, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, January 26, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 26, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 26, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, January 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 9, 2023SOU EXTENSION 2 FILED
Thursday, October 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 19, 2022SOU EXTENSION 1 FILED
Wednesday, October 19, 2022SOU EXTENSION 1 GRANTED
Friday, October 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023SOU EXTENSION 2 GRANTED
Saturday, March 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2023SOU EXTENSION 3 FILED
Thursday, October 19, 2023SOU EXTENSION 3 GRANTED
Saturday, October 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 4 FILED
Monday, March 4, 2024SOU EXTENSION 4 GRANTED
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 24, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2024SOU EXTENSION 5 GRANTED
Friday, October 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 24, 2024SOU EXTENSION 5 FILED
Wednesday, October 15, 2025ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 15, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED